Internal Medicine, Infectious Disease · Dallas, TX
NPI
1104060904
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
5200 Harry Hines Blvd
Dallas, TX, 75235
Phone (214) 590-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$725K
59,341 services
Medicare patients, 2024
650
Average age 70
Drug cost, 2024
$1.8M
1,266 prescriptions
Company payments, 2025
$22K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Uriel S Sandkovsky was code J0897 (injection, denosumab, 1 mg), 3,425 times for 48 patients. In total Uriel S Sandkovsky billed 59,341 services in 69 codes, and Medicare paid $725K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,425 | 48 | $19.52 | $67K |
| 99233 Hospital E&M - Subsequent | Facility | 1,376 | 282 | $92.43 | $127K |
| 99232 Hospital E&M - Subsequent | Facility | 872 | 314 | $61.42 | $54K |
| 99214 Office E&M - Established | Office | 373 | 170 | $83.34 | $31K |
| 99223 Hospital E&M - Initial | Facility | 317 | 267 | $133.63 | $42K |
| 96365 Intravenous Infusion, Hydration | Office | 247 | 61 | $46.13 | $11K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 105 | 21 | $4.69 | $493 |
| 96372 Injection Administration | Office | 103 | 57 | $8.61 | $886 |
| 99215 Office E&M - Established | Office | 50 | 37 | $128.19 | $6,409 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 38 | 31 | $12.98 | $493 |
| 99222 Hospital E&M - Initial | Facility | 28 | 28 | $96.24 | $2,695 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 19 | 19 | $83.20 | $1,581 |
| 99213 Office E&M - Established | Office | 16 | 14 | $45.27 | $724 |
| 36573 Venous Catheter Insertion | Office | 13 | 12 | $268.32 | $3,488 |
| 99204 Office E&M - New | Office | 12 | 12 | $132.10 | $1,585 |
By year: 2022 $847K for 104,940 services; 2023 $1.1M for 110,307 services; 2024 $725K for 59,341 services.
Medicare prescription drug claims, 2024
In 2024, the drug Uriel S Sandkovsky prescribed most often to Medicare patients was Ertapenem (Ertapenem Sodium), with 129 prescriptions and refills. In total Uriel S Sandkovsky wrote 1,266 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ertapenem Ertapenem Sodium | 129 | 132 | 43 | $59K |
| Ceftriaxone Ceftriaxone Sodium | 126 | 129 | 34 | $15K |
| Daptomycin Generic | 105 | 106 | 34 | $65K |
| Isoniazid Generic | 104 | 124 | 22 | $723 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 56 | 56 | Under 11 | $223K |
| Fluconazole Generic | 49 | 52 | 13 | $2,877 |
| Minocycline Hcl Generic | 35 | 40 | 23 | $649 |
| Dovato Dolutegravir Sodium/Lamivudine | 27 | 27 | Under 11 | $79K |
| Fetroja Cefiderocol Sulfate Tosylate | 27 | 27 | Under 11 | $146K |
| Azithromycin Generic | 25 | 31 | Under 11 | $599 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 23 | 24 | 11 | $6,684 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 22 | 22 | Under 11 | $320K |
| Ethambutol Hcl Generic | 22 | 26 | Under 11 | $1,290 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 20 | 26 | Under 11 | $562 |
| Moxifloxacin Hcl Generic | 20 | 20 | Under 11 | $1,551 |
Brand drugs: 336 claims; generic drugs: 930 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Uriel S Sandkovsky $22K ($22K in general payments such as food, travel and fees) from 17 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $15K.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 15 | $15K |
| Shionogi Inc 4507.T | 6 | $6,406 |
| ViiV Healthcare Company GSK | 8 | $205 |
| Aimmune Therapeutics, Inc. | 3 | $115 |
| Ferring Pharmaceuticals Inc. | 4 | $109 |
| Merck Sharp & Dohme LLC MRK | 4 | $90.51 |
| Insmed, Inc. INSM | 3 | $77.19 |
| Gilead Sciences, Inc. GILD | 3 | $69.07 |
| Astellas Pharma US Inc 4503.T | 3 | $67.45 |
| Abbvie Inc. ABBV | 1 | $24.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.